Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-deprivation Therapy”

501 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 501 results

Large-scale testing (Phase 3)Study completedNCT01020448
What this trial is testing

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 339
Not applicableStudy completedNCT01078545
What this trial is testing

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

Who this might be right for
Advanced Prostate CancerLower Urinary Tract Symptoms
Abbott 729
Testing effectiveness (Phase 2)Study completedNCT02789878
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 64
Not applicableStudy completedNCT06167824
What this trial is testing

Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 302
Large-scale testing (Phase 3)UnknownNCT00796458
What this trial is testing

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Who this might be right for
PainProstate Cancer
A.O.U. San Giovanni Battista di Torino, Italy 200
Not applicableStudy completedNCT04057859
What this trial is testing

PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training

Who this might be right for
Cancer of the Prostate
CMX Research 271
Early research (Phase 1)Study completedNCT02472275
What this trial is testing

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 8
Not applicableNot Yet RecruitingNCT06430411
What this trial is testing

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Who this might be right for
Prostate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more
Medical University of Vienna 500
Very early researchStudy completedNCT07069465
What this trial is testing

Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging

Who this might be right for
Prostate Cancer
Urology Clinics of North Texas 10
Testing effectiveness (Phase 2)Looking for participantsNCT04734730
What this trial is testing

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 70
Large-scale testing (Phase 3)Looking for participantsNCT06320067
What this trial is testing

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
University College, London 3,360
Testing effectiveness (Phase 2)Looking for participantsNCT03899077
What this trial is testing

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

Who this might be right for
Cancer of Prostate
Cancer Research Antwerp 202
Large-scale testing (Phase 3)Study completedNCT00067015
What this trial is testing

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 3
Not applicableLooking for participantsNCT07162987
What this trial is testing

Prehabilitation to Patients With Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)
Odense University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00181584
What this trial is testing

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Who this might be right for
Bone LossProstate Cancer
Massachusetts General Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06015321
What this trial is testing

An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma

Who this might be right for
Prostatic Adenocarcinoma
Samsung Medical Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT03942653
What this trial is testing

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

Who this might be right for
Salivary Gland Carcinoma
Manish Patel 20
Large-scale testing (Phase 3)Study completedNCT01220869
What this trial is testing

Degarelix in Taiwanese Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 110
Large-scale testing (Phase 3)Study completedNCT00295750
What this trial is testing

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 620
Large-scale testing (Phase 3)Study completedNCT00193856
What this trial is testing

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Who this might be right for
Prostate Cancer
Trans Tasman Radiation Oncology Group 1,071
Load More Results